Oral tofacitinib for successful treatment of refractory alopecia areata in preschool children-Reference-Cited by-同舟云学术

Oral tofacitinib for successful treatment of refractory alopecia areata in preschool children

Published:2022-09-22 Issue:12 Volume:36 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Geng S.L.¹,Gong T.²,Ji C.¹^ORCID,Su H.H.³

Affiliation:

1. Department of Dermatology, Institute of Dermatology and Venereology, Fujian Dermatology and Venereology Research Institute, Key Laboratory of Skin Cancer of Fujian Higher Education Institutions, the First Affiliated Hospital Fujian Medical University Fuzhou 350005 China

2. Central Laboratory the First Affiliated Hospital of Fujian Medical University Fuzhou 350005 China

3. Department of Dermatology Tianjin Children’s Hospital Tianjin 300074 China

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18447

Reference5 articles.

1. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents

2. JAK Inhibitors for the Treatment of Pediatric Alopecia Areata

3. Oral tofacitinib for the treatment of alopecia areata in pediatric patients